GT Biopharma (GTBP) had the highest return between 2002 and 2012 by a US stock, returning 483,285,371.4%.
| ASSET | YEARS | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 2002-2012 | 483,285,371.43% |
Cemtrex (CETX) | 2002-2012 | 339,494,430.33% |
Northern Oil & Gas (NOG) | 2002-2012 | 5,425,696.15% |
Sequans Communications (SQNS) | 2002-2012 | 2,819,177.11% |
Hirequest (HQI) | 2002-2012 | 1,475,550% |
Castellum (CTM) | 2002-2012 | 815,117.39% |
Perspective Therapeutics (CATX) | 2002-2012 | 259,900% |
India Globalization Capital (IGC) | 2002-2012 | 233,233.33% |
NextTrip (NTRP) | 2002-2012 | 231,900% |
Ring Energy (REI) | 2002-2012 | 195,233.33% |
QXO (QXO) | 2002-2012 | 115,105% |
Taoping (TAOP) | 2002-2012 | 109,107.28% |
Houston American Energy (HUSA) | 2002-2012 | 57,072.56% |
ProMIS Neurosciences (PMN) | 2002-2012 | 54,572.9% |
Aris Mining (ARMN) | 2002-2012 | 52,895.39% |
Ocean Power Technologies (OPTT) | 2002-2012 | 23,678.89% |
NetEase (NTES) | 2002-2012 | 22,581.29% |
VirnetX Holding Corp Common Stock (VHC) | 2002-2012 | 21,044.13% |
Kartoon Studios (TOON) | 2002-2012 | 20,900% |
Monster Beverage (MNST) | 2002-2012 | 19,824.66% |
Cementos Pacasmayo SAA ADR (CPAC) | 2002-2012 | 17,249.33% |
Metalla Royalty & Streaming (MTA) | 2002-2012 | 12,854.55% |
PharmaCyte Biotech (PMCB) | 2002-2012 | 12,610% |
MEDIFAST (MED) | 2002-2012 | 11,898.2% |
Nixxy (NIXX) | 2002-2012 | 11,718.18% |
